← All companiesCCitius Pharmaceuticals, Inc.
CTXR - CIK 0001506251
Citius Pharmaceuticals, Inc. net income by year
Citius Pharmaceuticals, Inc. (CTXR) reported net income of -$32.54M for fiscal year 2023, as filed in its audited annual report with the SEC.
CTXR annual net income
CTXR net income 2010-2023
| Fiscal year | Net Income | Change |
|---|
| FY 2023 | -$32.54M | +3.3% |
| FY 2022 | -$33.64M | -45.9% |
| FY 2021 | -$23.05M | -31.4% |
| FY 2020 | -$17.55M | -12.8% |
| FY 2019 | -$15.56M | -24.1% |
| FY 2018 | -$12.54M | -20.7% |
| FY 2017 | -$10.38M | -25.2% |
| FY 2016 | -$8.30M | -185.8% |
| FY 2015 |
Net Income of similar companies
Frequently asked questions
How has Citius Pharmaceuticals, Inc.'s net income changed over time?
Between fiscal 2010 and fiscal 2023, Citius Pharmaceuticals, Inc.'s net income declined from -$15.50K to -$32.54M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.